Pharmacokinetics and Pharmacodynamics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
“Pharmacokinetics and Pharmacodynamics” is a Section of the peer-reviewed open access journal Pharmaceutics, which is devoted to highlighting the importance of pharmacokinetics and pharmacodynamics in drug development for better understanding of drug action. The Section welcomes original research articles as well as review papers that address a variety of related topics to novel and significant scientific findings by in vitro, in vivo, and clinical studies. The manuscript mainly focused on descriptive pharmacokinetics lacking novelty and scientific significance will not be considered for review.
Covered topics include:
- Mechanisms and factors affecting drug absorption, distribution, metabolism, and excretion;
- Kinetics of drug disposition and therapeutic effects;
- Pharmacokinetics, pharmacodynamics, and pharmacometrics;
- Toxicokinetics and toxicodynamics;
- Mathematical model for the assessment of drug ADME;
- Model-based drug development;
- Translational mathematical modeling in drug development;
- Quantitative systems pharmacology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Model-Informed Drug Discovery and Development, 2nd Edition (Deadline: 20 April 2024)
- Transport and Metabolism of Small-Molecule Drugs, 2nd Edition (Deadline: 20 April 2024)
- Precision Dosing in Clinical Therapeutics: The Application of Pharmacokinetics and Pharmacometrics (Deadline: 30 April 2024)
- Development of Physiologically Based Pharmacokinetic (PBPK) Modeling (Deadline: 30 April 2024)
- Microfluidic Vascularized Tissue Model-Based Drug Transport and Pharmacokinetics (Deadline: 10 May 2024)
- Bioanalysis and Metabolomics, 2nd Edition (Deadline: 20 May 2024)
- New Insights into Physiologically Based Pharmacokinetic Modeling (Deadline: 20 May 2024)
- Pharmacokinetic and Pharmacodynamic Considerations for Drugs Used in the Treatment of Cardiovascular Diseases (Deadline: 31 May 2024)
- Pharmacokinetics and Drug–Drug Interactions of Novel Psychotropic Drugs (Deadline: 31 May 2024)
- Physiologically-Based Pharmacokinetics (PBPK) and Biopharmaceutics (PBBM) Modeling for Formulation Development (Deadline: 31 May 2024)
- Formulation Strategies to Optimize Drug Pharmacokinetics and Improve Therapeutic Outcomes (Deadline: 10 June 2024)
- Dose Optimization of Traditional and New Drug Formulations in Veterinary and Human Medicine (Deadline: 30 June 2024)
- Optimizing Drug Safety and Efficacy: Pharmacokinetic Modeling (Deadline: 30 June 2024)
- ADME Properties in the Drug Delivery (Deadline: 10 July 2024)
- Recent Advances in Polymeric Nanoparticle-Based Drug Delivery System for Cancer Therapy (Deadline: 31 July 2024)
- Novel Anti-cancer Compounds: Drug Metabolism and Absorption (Deadline: 31 July 2024)
- Current Research in Drug Metabolism and Drug–Drug Interactions (DDIs) (Deadline: 31 July 2024)
- Pharmacokinetics and Artificial Intelligence for Drug Predictions (Deadline: 10 August 2024)
- Role of Pharmacokinetics in Drug Development and Evaluation (Deadline: 20 August 2024)
- Population Pharmacokinetics and Its Clinical Applications (Deadline: 31 August 2024)
- Advances in Pharmacokinetics and Drug-Drug Interactions (Deadline: 31 August 2024)
- Toxicokinetics in Renal Disease (Deadline: 31 August 2024)
- Advanced In Silico Methods and Digital Platforms for the Prediction of ADMET and Pharmacokinetics Properties (Deadline: 30 September 2024)
- Advances in Pharmacokinetics, Pharmacodynamics and Drug Interactions, 2nd Edition (Deadline: 30 September 2024)
- Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy, 2nd Edition (Deadline: 10 October 2024)
- Advances in Pharmacokinetics and Drug Interactions (Deadline: 20 October 2024)
